Searched for
WCK 771
Wockhardt Ltd rallies on receiving QIDP status for two drugsThis is the first instance of an Indian pharmaceutical company receiving a QIDP status, Wockhardt said in a release issued.01 Sep, 2014, 04.47 PM IST- Nifty breaches 8,000-mark for first time, Sensex hits new peak; top 15 stocksThe 50-share NSE Nifty index breached the 8,000-mark for the first time ever in trade on Monday and BSE Sensex logged a new peak of 26,854....01 Sep, 2014, 10.43 AM IST
- Fifteen stocks in focus in Monday morning tradeThe 50-share Nifty index surged over 40 points to hit its fresh record high of 8,007.95, led by gains in NTPC, Coal India, Hindalco, L&T an...01 Sep, 2014, 09.32 AM IST
- Wockhardt's WCK 771 and WCK 2349 recieve QIDP status from US FDAThis is the first instance of an Indian pharmaceutical company receiving a QIDP status, Wockhardt said in a release issued here.01 Sep, 2014, 04.41 AM IST
- USFDA grants Qualified Infectious Disease Product status to two Wockhardt drugsTwo drugs - WCK 771 and WCK 2349 - have received QIDP status, which allows fast-track review of the drug application by the USFDA.31 Aug, 2014, 07.11 PM IST
- Wockhardt to spin off R&D businessDrug maker Wockhardt said on Friday it will spin off its R&D business and list the new company on stock exchange on January 1, 2009.19 Jan, 2008, 12.00 AM IST
- Wockhardt to hive off innovative R&D businessWockhardt planning to spin off its innovative R and D business into a separate co. The move is being contemplated to seek funding support f...12 Nov, 2007, 05.30 AM IST
- Indian pharma cos close to blockbuster breakthroughIndian pharma majors may manage to market their first indi-genous "blockbuster drugs" or new chemical entities (NCEs) in the next four year...07 Nov, 2006, 01.37 AM IST
- Wockhardt in talks to out-license research moleculesWockhardt is likely to out-license some of its research molecules to global pharma companies.07 Jun, 2006, 12.28 AM IST
Load More
